Annual FCF
-$194.20 M
+$80.42 M+29.28%
31 December 2023
Summary:
Atara Biotherapeutics annual free cash flow is currently -$194.20 million, with the most recent change of +$80.42 million (+29.28%) on 31 December 2023. During the last 3 years, it has fallen by -$8.93 million (-4.82%). ATRA annual FCF is now -3153.48% below its all-time high of -$5.97 million, reached on 31 December 2013.ATRA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$3.99 M
+$6.68 M+62.63%
30 September 2024
Summary:
Atara Biotherapeutics quarterly free cash flow is currently -$3.99 million, with the most recent change of +$6.68 million (+62.63%) on 30 September 2024. Over the past year, it has increased by +$47.64 million (+92.27%). ATRA quarterly FCF is now -453.95% below its all-time high of $1.13 million, reached on 30 June 2013.ATRA Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$94.85 M
+$47.64 M+33.43%
30 September 2024
Summary:
Atara Biotherapeutics TTM free cash flow is currently -$94.85 million, with the most recent change of +$47.64 million (+33.43%) on 30 September 2024. Over the past year, it has increased by +$105.81 million (+52.73%). ATRA TTM FCF is now -5196.04% below its all-time high of -$1.79 million, reached on 30 June 2013.ATRA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATRA Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +29.3% | +92.3% | +52.7% |
| 3 y3 years | -4.8% | +93.7% | +52.4% |
| 5 y5 years | +10.0% | +92.6% | +60.7% |
ATRA Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -4.8% | +29.3% | at high | +95.4% | at high | +65.5% |
| 5 y | 5 years | -4.8% | +29.3% | at high | +95.4% | at high | +65.5% |
| alltime | all time | -3153.5% | +29.3% | -453.9% | +95.4% | -5196.0% | +65.5% |
Atara Biotherapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.99 M(-62.6%) | -$94.85 M(-33.4%) |
| June 2024 | - | -$10.67 M(-64.1%) | -$142.49 M(-23.0%) |
| Mar 2024 | - | -$29.74 M(-41.1%) | -$185.11 M(-4.7%) |
| Dec 2023 | -$194.20 M(-29.3%) | -$50.45 M(-2.3%) | -$194.20 M(-3.2%) |
| Sept 2023 | - | -$51.63 M(-3.1%) | -$200.67 M(-6.3%) |
| June 2023 | - | -$53.30 M(+37.3%) | -$214.23 M(-5.3%) |
| Mar 2023 | - | -$38.83 M(-31.8%) | -$226.32 M(-17.6%) |
| Dec 2022 | -$274.62 M(+18.8%) | -$56.92 M(-12.7%) | -$274.62 M(+7.9%) |
| Sept 2022 | - | -$65.19 M(-0.3%) | -$254.44 M(+0.9%) |
| June 2022 | - | -$65.38 M(-25.0%) | -$252.09 M(+0.7%) |
| Mar 2022 | - | -$87.13 M(+137.2%) | -$250.34 M(+8.3%) |
| Dec 2021 | -$231.10 M(+24.7%) | -$36.73 M(-41.5%) | -$231.10 M(+16.1%) |
| Sept 2021 | - | -$62.83 M(-1.3%) | -$199.09 M(+4.9%) |
| June 2021 | - | -$63.64 M(-6.3%) | -$189.72 M(+2.7%) |
| Mar 2021 | - | -$67.89 M(+1338.1%) | -$184.79 M(-0.3%) |
| Dec 2020 | -$185.27 M(-23.2%) | -$4.72 M(-91.2%) | -$185.27 M(-23.4%) |
| Sept 2020 | - | -$53.46 M(-8.9%) | -$241.95 M(-0.1%) |
| June 2020 | - | -$58.71 M(-14.1%) | -$242.13 M(+1.4%) |
| Mar 2020 | - | -$68.38 M(+11.4%) | -$238.74 M(-1.1%) |
| Dec 2019 | -$241.36 M(+11.9%) | -$61.40 M(+14.5%) | -$241.36 M(-0.1%) |
| Sept 2019 | - | -$53.63 M(-3.1%) | -$241.54 M(+0.4%) |
| June 2019 | - | -$55.33 M(-22.1%) | -$240.51 M(+3.6%) |
| Mar 2019 | - | -$71.00 M(+15.3%) | -$232.06 M(+7.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$215.70 M(+100.2%) | -$61.59 M(+17.1%) | -$215.70 M(+14.3%) |
| Sept 2018 | - | -$52.60 M(+12.2%) | -$188.74 M(+16.1%) |
| June 2018 | - | -$46.88 M(-14.2%) | -$162.57 M(+16.9%) |
| Mar 2018 | - | -$54.63 M(+57.7%) | -$139.12 M(+29.1%) |
| Dec 2017 | -$107.73 M(+70.9%) | -$34.63 M(+31.1%) | -$107.73 M(+13.1%) |
| Sept 2017 | - | -$26.42 M(+12.7%) | -$95.26 M(+12.3%) |
| June 2017 | - | -$23.44 M(+0.8%) | -$84.80 M(+16.3%) |
| Mar 2017 | - | -$23.24 M(+4.9%) | -$72.90 M(+15.6%) |
| Dec 2016 | -$63.05 M(+68.4%) | -$22.16 M(+38.8%) | -$63.05 M(+20.0%) |
| Sept 2016 | - | -$15.97 M(+38.4%) | -$52.55 M(+6.2%) |
| June 2016 | - | -$11.54 M(-13.8%) | -$49.49 M(+12.0%) |
| Mar 2016 | - | -$13.38 M(+14.7%) | -$44.20 M(+18.0%) |
| Dec 2015 | -$37.45 M(+124.6%) | -$11.66 M(-9.7%) | -$37.45 M(+21.7%) |
| Sept 2015 | - | -$12.91 M(+106.9%) | -$30.78 M(+40.2%) |
| June 2015 | - | -$6.24 M(-5.8%) | -$21.96 M(+7.7%) |
| Mar 2015 | - | -$6.63 M(+32.7%) | -$20.38 M(+22.2%) |
| Dec 2014 | -$16.67 M(+179.3%) | -$4.99 M(+21.9%) | -$16.67 M(+17.7%) |
| Sept 2014 | - | -$4.10 M(-12.2%) | -$14.17 M(+20.5%) |
| June 2014 | - | -$4.67 M(+59.9%) | -$11.76 M(+97.1%) |
| Mar 2014 | - | -$2.92 M(+17.2%) | -$5.97 M(0.0%) |
| Dec 2013 | -$5.97 M | -$2.49 M(+47.4%) | -$5.97 M(+71.5%) |
| Sept 2013 | - | -$1.69 M(-249.9%) | -$3.48 M(+94.3%) |
| June 2013 | - | $1.13 M(-138.6%) | -$1.79 M(-38.6%) |
| Mar 2013 | - | -$2.92 M | -$2.92 M |
FAQ
- What is Atara Biotherapeutics annual free cash flow?
- What is the all time high annual FCF for Atara Biotherapeutics?
- What is Atara Biotherapeutics annual FCF year-on-year change?
- What is Atara Biotherapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Atara Biotherapeutics?
- What is Atara Biotherapeutics quarterly FCF year-on-year change?
- What is Atara Biotherapeutics TTM free cash flow?
- What is the all time high TTM FCF for Atara Biotherapeutics?
- What is Atara Biotherapeutics TTM FCF year-on-year change?
What is Atara Biotherapeutics annual free cash flow?
The current annual FCF of ATRA is -$194.20 M
What is the all time high annual FCF for Atara Biotherapeutics?
Atara Biotherapeutics all-time high annual free cash flow is -$5.97 M
What is Atara Biotherapeutics annual FCF year-on-year change?
Over the past year, ATRA annual free cash flow has changed by +$80.42 M (+29.28%)
What is Atara Biotherapeutics quarterly free cash flow?
The current quarterly FCF of ATRA is -$3.99 M
What is the all time high quarterly FCF for Atara Biotherapeutics?
Atara Biotherapeutics all-time high quarterly free cash flow is $1.13 M
What is Atara Biotherapeutics quarterly FCF year-on-year change?
Over the past year, ATRA quarterly free cash flow has changed by +$47.64 M (+92.27%)
What is Atara Biotherapeutics TTM free cash flow?
The current TTM FCF of ATRA is -$94.85 M
What is the all time high TTM FCF for Atara Biotherapeutics?
Atara Biotherapeutics all-time high TTM free cash flow is -$1.79 M
What is Atara Biotherapeutics TTM FCF year-on-year change?
Over the past year, ATRA TTM free cash flow has changed by +$105.81 M (+52.73%)